RFA
KRYS icon

Reyes Financial Architecture’s Krystal Biotech KRYS Stock Holding History

Reyes Financial Architecture’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.2K Hold
100
– – 0.02% 191
2026
Q1 		$25.8K Hold
100
– – 0.02% 216
2025
Q4 		$24.7K Hold
100
– – 0.02% 211
2025
Q3 		$17.7K Hold
100
– – 0.01% 214
2025
Q2 		$13.7K Buy
+100
New +$14.7K 0.01% 211

Other funds holding KRYS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Reyes Financial Architecture's KRYS Position: Q2 2026 in Review

Reyes Financial Architecture held its Krystal Biotech (KRYS) position steady in Q2 2026 at 100 shares worth $37.2K. The position accounts for 0.02% of the portfolio, ranked #191.

Reyes Financial Architecture first reported a position in KRYS in Q2 2025 and has held it in 5 quarters since. 74 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Reyes Financial Architecture held 100 shares of Krystal Biotech worth $37.2K as of Q2 2026.
  • Reyes Financial Architecture left its Krystal Biotech share count unchanged in Q2 2026.
  • Krystal Biotech made up 0.02% of Reyes Financial Architecture's portfolio in Q2 2026, its #191 holding.
  • Reyes Financial Architecture first reported a position in Krystal Biotech in Q2 2025 and has held it in 5 quarters since.
  • 74 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Reyes Financial Architecture's 13F filing for Q2 2026, filed 17 Jul 2026.